Pisansky TM - Search Results

1

Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis.

Kishan AU, Sun Y, Hartman H, Pisansky TM, Bolla M, Neven A, Steigler A, Denham JW, Feng FY, Zapatero A, Armstrong JG, Nabid A, Carrier N, Souhami L, Dunne MT, Efstathiou JA, Sandler HM, Guerrero A, Joseph D, Maingon P, de Reijke TM, Maldonado X, Ma TM, Romero T, Wang X, Rettig MB, Reiter RE, Zaorsky NG, Steinberg ML, Nickols NG, Jia AY, Garcia JA, Spratt DE; MARCAP Consortium group. Kishan AU, et al. Among authors: pisansky tm. Lancet Oncol. 2022 Feb;23(2):304-316. doi: 10.1016/S1470-2045(21)00705-1. Epub 2022 Jan 17. Lancet Oncol. 2022. PMID: 35051385

2

Inflammatory breast cancer: integration of irradiation, surgery, and chemotherapy.

Pisansky TM, Schaid DJ, Loprinzi CL, Donohue JH, Schray MF, Schomberg PJ. Pisansky TM, et al. Am J Clin Oncol. 1992 Oct;15(5):376-87. Am J Clin Oncol. 1992. PMID: 1524037

3

Prostate-specific antigen as a pretherapy prognostic factor in patients treated with radiation therapy for clinically localized prostate cancer.

Pisansky TM, Cha SS, Earle JD, Durr ED, Kozelsky TF, Wieand HS, Oesterling JE. Pisansky TM, et al. J Clin Oncol. 1993 Nov;11(11):2158-66. doi: 10.1200/JCO.1993.11.11.2158. J Clin Oncol. 1993. PMID: 7693880

4

Conservative therapy of breast cancer. The Mayo Clinic experience.

Halyard MY, Grado GL, Schomberg PJ, Weaver AL, Grant CS, Pisansky TM. Halyard MY, et al. Among authors: pisansky tm. Am J Clin Oncol. 1996 Oct;19(5):445-50. doi: 10.1097/00000421-199610000-00004. Am J Clin Oncol. 1996. PMID: 8823471

5

Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer.

Pisansky TM, Kozelsky TF, Myers RP, Hillman DW, Blute ML, Buskirk SJ, Cheville JC, Ferrigni RG, Schild SE. Pisansky TM, et al. J Urol. 2000 Mar;163(3):845-50. J Urol. 2000. PMID: 10687990

6

Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical margin.

Leibovich BC, Engen DE, Patterson DE, Pisansky TM, Alexander EE, Blute ML, Bergstralh EJ, Zincke H. Leibovich BC, et al. Among authors: pisansky tm. J Urol. 2000 Apr;163(4):1178-82. J Urol. 2000. PMID: 10737490

7

Predictive factors in localized prostate cancer: implications for radiotherapy and clinical trial design.

Pisansky TM, Davis BJ. Pisansky TM, et al. Semin Urol Oncol. 2000 May;18(2):93-107. Semin Urol Oncol. 2000. PMID: 10875449 Review.

8

Lymph node-positive prostate cancer: evaluation of the results of the combination of androgen deprivation therapy and radiation therapy.

Buskirk SJ, Pisansky TM, Atkinson EJ, Schild SE, O'Brien PC, Wolfe JT, Zincke H. Buskirk SJ, et al. Among authors: pisansky tm. Mayo Clin Proc. 2001 Jul;76(7):702-6. doi: 10.4065/76.7.702. Mayo Clin Proc. 2001. PMID: 11444402

9

Adjuvant external radiation therapy following radical prostatectomy for node-negative prostate cancer.

Davis BJ, Pisansky TM, Leibovich BC. Davis BJ, et al. Among authors: pisansky tm. Curr Opin Urol. 2003 Mar;13(2):117-22. doi: 10.1097/00042307-200303000-00006. Curr Opin Urol. 2003. PMID: 12584471 Review.

10

Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era.

Kuban DA, Thames HD, Levy LB, Horwitz EM, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Sandler HM, Shipley WU, Zelefsky MJ, Zietman AL. Kuban DA, et al. Among authors: pisansky tm. Int J Radiat Oncol Biol Phys. 2003 Nov 15;57(4):915-28. doi: 10.1016/s0360-3016(03)00632-1. Int J Radiat Oncol Biol Phys. 2003. PMID: 14575822

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

171 results

Search Page